a

atai Life Sciences

137 employees

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

Investor insights

Sectors invested in

Pharmaceutical5
Biotechnology5
Health Care5
Life Science2
Ontologies1
Wellness1
Personal Health1
Analytics1
Information Technology1
Machine Learning1
KOL discovery1
Text Analytics1
Bigdata & Analytics1
Entity Normalization1
biomarker1
Continuous Analytics1
Artificial Intelligence1
Computer vision1
Blockchain1
Natural Language Processing1

Funding rounds participated in

$3M sweet spot round size

Most of their 6 investments are in rounds between $2M and $12M

Investor type

Corporate Venture Capital

Basic info

Industry

biotechnology research

Sectors

Biotechnology
psychedelics
Life Science
Therapeutics
mental health disorders
Health Care

Date founded

2018

Investments made

-

- raised $3M on January 9, 2023

Investors: atai Life Sciences

-

- raised $3M on February 1, 2022

Investors: atai Life Sciences

-

- raised $12M on March 15, 2021

Investors: atai Life Sciences

-

- raised $2M on March 15, 2021

Investors: atai Life Sciences

C

COMPASS Pathways raised $80M on April 27, 2020

Investors: Presight Capital, Skyviews Life Science, __able, Soleus Capital Management, L.P., Founders Fund, Camden Partners, Perceptive Advisors and atai Life Sciences

I

Innoplexus raised undisclosed on April 24, 2019

Investors: FinLab AG, Block.one and atai Life Sciences

FAQ